Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

about

Urticaria and angioedema as possible reactions of omalizumab.

P2860

Q54988172-06722298-A50F-4546-A4C0-D7F84F21ADC8

P2860

Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

Item

http://www.wikidata.org/entity/Q38445637

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Chronic spontaneous urticaria ...... chronic spontaneous urticaria.

@en

type

Item

label

Chronic spontaneous urticaria ...... chronic spontaneous urticaria.

@en

prefLabel

Chronic spontaneous urticaria ...... chronic spontaneous urticaria.

@en

P1476

Chronic spontaneous urticaria ...... chronic spontaneous urticaria.

@en

P2093

Christian Termeer

http://www.w3.org/2001/XMLSchema#string

Hjalmar Kurzen

http://www.w3.org/2001/XMLSchema#string

Klaus Strömer

http://www.w3.org/2001/XMLSchema#string

Marcus Maurer

http://www.w3.org/2001/XMLSchema#string

Petra Staubach

http://www.w3.org/2001/XMLSchema#string

Rolf Ostendorf

http://www.w3.org/2001/XMLSchema#string

P2860

Up-dosing with bilastine results in improved effectiveness in cold contact urticaria

Leukotriene receptor antagonists for chronic urticaria: a systematic review.

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria.

Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy.

Acquired cold urticaria symptoms can be safely prevented by ebastine.

Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.

Fexofenadine in higher doses in chronic spontaneous urticaria

The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommendations.

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update.

Omalizumab is an effective and rapidly acting therapy in difficult-to-treat chronic urticaria: a retrospective clinical analysis.

P304

419-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/DDG.12633_SUPPL

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275527837

http://www.w3.org/2001/XMLSchema#string

P698

25918085

http://www.w3.org/2001/XMLSchema#string

Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

about

P2860

P2860

Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698